Bis(7)-tacrine, a novel acetylcholinesterase inhibitor, reverses AF64A- induced deficits in navigational memory in rats

Neuroscience Letters

Volumn 282, Issue 3, 2000, Pages 165-168

  Liu, Jing ^a   Ho, Wing Lok ^a   Lee, Nelson Tze Kin ^a   Carlier, Paul R ^a   Pang, Yuan Ping ^b   Han, Yi Fan ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b MAYO CLINIC CANCER CENTER   (United States)

Author keywords

AF64A; Alzheimer's disease; Bis(7) tacrine; Cholinesterase inhibitors; Water maze

Indexed keywords

CHOLINE ACETYLTRANSFERASE; CHOLINESTERASE INHIBITOR; ETHYLCHOLINE MUSTARD AZIRIDINIUM; SODIUM CHLORIDE;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HIPPOCAMPUS; NONHUMAN; PALLIATIVE THERAPY; PRIORITY JOURNAL; RAT; SPATIAL MEMORY;

ANIMALS; AZIRIDINES; CHOLINE; CHOLINESTERASE INHIBITORS; ESCAPE REACTION; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; MEMORY; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; TACRINE; TOXINS, BIOLOGICAL;

EID: 0034708402     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)00905-8     Document Type: Article

References (18)

1. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
2. Carlier P.R., Han Y.F., Chow E.S.H., Li C.P.L., Wang H., Lieu T.X., Wong H.S., Pang Y.P. Evaluation of short-tether bis(7)-tacrine AChE inhibitors: a further test of the dual bindings site hypothesis. Bioorg. Med. Chem. 7:1999;351-357.
3. Cheng D.H., Tang X.C. Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities. Pharmacol. Biochem. Behav. 60:1998;377-386.
4. Fisher A., Mantione C.R., Abraham D.J., Hanin I. Long-term central cholinergic hypofunction induced in mice by ethylcholine aziridinium ion (AF64A) in vivo. J. Pharmacol. Exp. Ther. 222:1982;140-145.
5. Hanin I. The AF64A model of cholinergic hypofunction: an update. Life Sci. 58:1996;1955-1964.
6. Hanin I. Pharmacological induction of cholinergic hypofunction as a tool for evaluating cholinergic therapies. Becker R., Giacobini E. Alzheimer Disease: From Molecular Biology to Therapy. 1996;165-170 Birkhauser, Boston.
7. Jarrard L.E., Kant G.J., Meyerhoff J.L., Levy A. Behavioral and neurochemical effects of intraventricular AF64A administration in rats. Pharmacol. Biochem. Behav. 21:1984;273-280.
8. Leventer S., McKeag D., Clancy M., Wulfert E., Hanin I. Intracerebroventricular administration of ethylcholine mustard aziridinium ion (AF64A) reduces release of acetylcholine from rat hippocampal slices. Neuropharmacology. 24:1985;453-459.
9. A receptor antagonist. NeuroReport. 10:1999;795-800.
10. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods. 11:1984;47-60.
11. Pang Y.P., Quiram P., Jelacic T., Hong F., Brimijoin S. Highly potent, selective, and low cost bis-tetrahyroaminoacrine inhibitors of acetylcholinesterase. J. Biol. Chem. 271:1996;23646-23649.
12. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd edn. 1986;Academic Press, New York.
13. Robbins T.W., McAlonan G., Muir J.L., Everitt B.J. Cognitive enhances in theory and practice: studies of the cholinergic hypothesis of cognitive deficits in Alzheimer's disease. Behav. Brain Res. 83:1997;15-23.
14. Rogers S.L., Yamanishi Y., Yamatsu K. E2020: the pharmacology of a piperidine cholinesterase inhibitor. Becker R., Giacobini E. Cholinergic Basis For Alzheimer Disease Therapy. 1991;314-320 Birkhauser, Boston.
15. Wang H., Carlier P.R., Ho W.L., Lee N.T.K., Li C.P.L., Pang Y.P., Han Y.F. Effects of bis(7)-tacrine, a novel anti-Alzheimer's agent, on rat brain AChE. NeuroReport. 10:1999;789-793.
16. Wang H., Carlier P.R., Ho W.L., Lee N.T.K., Pang Y.P., Han Y.F. Attenuation of scopolamine-induced deficits in navigational memory performance in rats by bis(7)-tacrine, a novel dimeric AChE inhibitor. Acta Pharmacol Sin. 20:1999;211-217.
17. Watkins P.B., Zimmerman H.J., Knapp M.J., Gracon S.I., Lewis K.W. Heptatotoxic effects of tacrine administration in patients with Alzheimer's disease. J. Am. Med. Assoc. 271:1994;992-998.
18. Xiong Z.Q., Han Y.F., Tang X.C. Huperzine A ameliorates the spatial working memory impairments induced by AF64A. NeuroReport. 6:1995;2221-2224.